1
|
Sano D, Lekakis L, Feng L, Nastoupil L, Jain M, Spiegel J, Dahiya S, Lin Y, Ghobadi A, Lunning M, Hill B, Reagan P, Oluwole O, McGuirk J, Sehgal A, Deol A, Charalambos A, Goy A, Munoz J, Cashen A, Bennani N, Rapoport A, Vose J, Miklos D, Locke F, Neelapu S. SAFETY AND EFFICACY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN OLDER PATIENTS: RESULTS FROM THE US LYMPHOMA CAR-T CONSORTIUM. Hematol Oncol 2019. [DOI: 10.1002/hon.113_2630] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- D. Sano
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - L. Lekakis
- Bone Marrow Transplant/Hematology; University Of Miami; Miami United States
| | - L. Feng
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - L.J. Nastoupil
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - M.D. Jain
- Blood; Bone Marrow Transplant and Cellular Therapy, Moffitt Cancer Center; Tampa United States
| | - J.Y. Spiegel
- Hematology; Stanford University; Stanford United States
| | - S. Dahiya
- Hematology/Bone Marrow Transplant; University of Maryland Medical Center; Baltimore United States
| | - Y. Lin
- Hematology; Mayo Clinic; Rochester United States
| | - A. Ghobadi
- Bone Marrow Transplant; Washington University Medical Campus; Saint Louis United States
| | - M. Lunning
- Hematology/Oncology; University of Nebraska Medical Center; Omaha United States
| | - B.T. Hill
- Hematology and Medical Oncology; Cleveland Clinic; Cleveland United States
| | - P. Reagan
- Lymphoma; University of Rochester Medical Center/Wilmot Cancer institute; Rochester United States
| | - O. Oluwole
- Hematology and Oncology; Vanderbilt University Medical Center; Nashville United States
| | - J. McGuirk
- Hematological Malignancies and Cellular Therapeutic; The University of Kansas Health System; Kansas City United States
| | - A. Sehgal
- Hematology and Oncology; UPMC Hillman Cancer Center; Pittsburgh United States
| | - A. Deol
- Department of Oncology; Wayne State University/Karmanos Cancer Center; Detroit United States
| | - A. Charalambos
- Hematology and Bone Marrow Transplant; University of California San francisco; San Francisco United States
| | - A.H. Goy
- Hematology and Oncology; Hackensack University Medical Center; Hackensack United States
| | - J. Munoz
- Lymphoma/Myeloma; Banner MD Anderson Cancer Center; Gilbert United States
| | - A. Cashen
- Bone Marrow Transplantation & Leukemia; Washington University Medical School; St. Louis United States
| | - N.N. Bennani
- Hematology; Mayo Clinic; Rochester United States
| | - A.P. Rapoport
- Hematology/Bone Marrow Transplant; University of Maryland Medical Center; Baltimore United States
| | - J.M. Vose
- Hematology/Oncology; University of Nebraska Medical Center; Omaha United States
| | - D.B. Miklos
- Hematology; Stanford University; Stanford United States
| | - F.L. Locke
- Blood; Bone Marrow Transplant and Cellular Therapy, Moffitt Cancer Center; Tampa United States
| | - S.S. Neelapu
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| |
Collapse
|